基因表现市场 - 按流程、产品、应用、技术、产能、最终用户和预测，2024 年 - 2032 年

Gene Expression Market - By Process, Product, Application, Techniques, Capacity, End-user & Forecast, 2024 - 2032

出版日期: 2024年03月01日 | 出版商:

Global Market Insights Inc. | 英文 230 Pages | 商品交期: 2-3个工作天内

价格

简介目录

由于越来越多地采用下一代定序 (NGS) 技术对 RNA 样本进行高通量定序以提供全面的转录组资料，因此从2024 年到2032 年，基因表现市场规模预计将达到7% 以上的复合年增长率。基因表现分析在临床研究和诊断中发挥着至关重要的作用，特别是在癌症、传染病和罕见遗传性疾病领域。学术机构、研究组织和生物技术公司不断努力推动基因表现分析的进步，例如获得尖端技术以及转化为临床应用，这将推动市场成长。举例来说，2023 年 8 月，马里兰大学 (UMD) 发起的一项新研究揭示了支撑基因表现的复杂过程，扩大了医学应用。

整个产业分为流程、产品、应用、技术、产能、最终用户和地区。

就流程而言，到 2032 年，样本采集领域的基因表现市场价值复合年增长率将达到 6.4%。血液样本经常透过静脉穿刺用于基因表现分析。透过研究健康和患病组织中的基因表达，研究人员正在确定潜在的药物标靶来评估候选药物的功效。为此，用于改善治疗结果的个人化医疗方法的不断发展将促进该细分市场的成长。

在应用方面，预计2024年至2032年，临床诊断领域的基因表现产业将以7.5%的复合年增长率扩张。从而提供更准确的诊断和治疗。该技术还有助于识别预后和预测生物标誌物，以提供有关疾病进展和某些治疗效果的有价值的资讯。

从地区来看，由于个人化医疗的需求不断增加，预计2024年至2032年亚太地区基因表现市场规模的复合年增长率将达到7.5%。由于慢性病患病率上升，该地区存在多样化的患者群体，使其成为临床研究的有吸引力的目的地。据估计，2022年印度医生与人口的比例为1：834 政府对积极推动和资助基因组学研究的支持不断升级，将进一步促进该地区产业的成长。

主要动向：按地区
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 南非
- 沙乌地阿拉伯
- 中东和非洲其他地区

第 12 章：公司简介

Agilent Technologies, Inc.
Bio-Rad Laboratories, Inc.
F. Hoffmann-La Roche Ltd.
GE HealthCare Technologies, Inc.
Illumina, Inc.
Oxford Nanopore Technologies Plc.
Pacific Biosciences of California, Inc.
PerkinElmer, Inc.
Promega Corporation
Qiagen N.V.
Thermo Fisher Scientific Inc.

简介目录

Product Code: 8370

Gene Expression Market size is poised to depict over 7% CAGR from 2024-2032, on account of the rising adoption of next-generation sequencing (NGS) technologies for high-throughput sequencing of RNA samples to provide comprehensive transcriptomic data. Gene expression analysis is playing a critical role in clinical research and diagnostics, particularly in the fields of cancer, infectious diseases, and rare genetic disorders. Rising efforts by academic institutions, research organizations, and biotech companies for advancements in gene expression analysis like access to cutting-edge technologies, and translation into clinical applications will drive the market growth. To illustrate, in August 2023, a new study initiated by the University of Maryland (UMD) shed light on the intricate processes underpinning gene expression for broadening applications in medicine.

The overall industry is segmented into process, product, application, technique, capacity, end-user, and region.

In terms of process, the gene expression market value from the sample collection segment will witness 6.4% CAGR through 2032. The growth can be ascribed to the intensifying need for providing valuable insights into the activity of genes. Blood samples are frequently used for gene expression analysis by deploying venipuncture. With the study of the expression of genes in healthy and diseased tissues, researchers are identifying potential drug targets to assess the efficacy of candidate drugs. To that end, the rising development of personalized medicine approaches to improve treatment outcomes will add to the segment growth.

With respect to application, the gene expression industry from the clinical diagnostics segment is expected to expand at 7.5% CAGR from 2024 to 2032. By analyzing gene expression patterns, clinicians can identify specific gene signatures associated with different disease subtypes to render more accurate diagnosis and personalized treatment. This technique also helps identify prognostic and predictive biomarkers to provide valuable information about the progression of diseases and the efficacy of certain treatments.

Regionally, the Asia Pacific gene expression market size is expected to observe 7.5% CAGR from 2024 to 2032, due to the increasing demand for personalized medicine. The presence of diverse patient population across the region due to the rising prevalence of chronic diseases makes it an attractive destination for clinical studies. It has been estimated that the doctor-population ratio in India was 1:834 in 2022. The escalating government support for actively promoting and funding genomics research will further contribute to the regional industry growth.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360 degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Technological advances that enhance gene expression
  - 3.2.1.2 Growing adoption of personalized medicine
  - 3.2.1.3 High investment in genomic research
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost of the instruments
  - 3.2.2.2 Lack of skilled labor
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Porter's analysis
- 3.5.1 Supplier power
- 3.5.2 Buyer power
- 3.5.3 Threat of new entrants
- 3.5.4 Threat of substitutes
- 3.5.5 Industry rivalry
3.6 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive positioning matrix
4.4 Strategic dashboard

Chapter 5 Market Estimates and Forecast, By Process, 2018 - 2032 ($ Million)

5.1 Key trends
5.2 Sample collection
5.3 Purification
5.4 cDNA synthesis & conversion
5.5 PCR analysis
5.6 Data analysis & interpretation

Chapter 6 Market Estimates and Forecast, By Product, 2018 - 2032 ($ Million)

6.1 Key trends
6.2 Consumables
- 6.2.1 Reagents
- 6.2.2 DNA chips
6.3 Instruments
- 6.3.1 PCR
- 6.3.2 NGS
- 6.3.3 DNA microarray
- 6.3.4 Other instruments
6.4 Services

Chapter 7 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Million)

7.1 Key trends
7.2 Drug discovery & development
7.3 Clinical diagnostics
7.4 Biotech & microbiology
7.5 Other applications

Chapter 8 Market Estimates and Forecast, By Technique, 2018 - 2032 ($ Million)

8.1 Key trends
8.2 RNA expression
8.3 Promoter analysis
8.4 Protein expression & posttranslational modification analysis

Chapter 9 Market Estimates and Forecast, By Capacity, 2018 - 2032 ($ Million)

9.1 Key trends
9.2 Low- to mid- plex
9.3 High-plex

Chapter 10 Market Estimates and Forecast, By End-User, 2018 - 2032 ($ Million)

10.1 Key trends
10.2 Pharmaceutical and biotechnology companies
10.3 Diagnostic laboratories
10.4 Academic research centers

Chapter 11 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Million)

11.1 Key trends, by region
11.2 North America
- 11.2.1 U.S.
- 11.2.2 Canada
11.3 Europe
- 11.3.1 Germany
- 11.3.2 UK
- 11.3.3 France
- 11.3.4 Spain
- 11.3.5 Italy
- 11.3.6 Rest of Europe
11.4 Asia Pacific
- 11.4.1 Japan
- 11.4.2 China
- 11.4.3 India
- 11.4.4 Australia
- 11.4.5 South Korea
- 11.4.6 Rest of Asia Pacific
11.5 Latin America
- 11.5.1 Brazil
- 11.5.2 Mexico
- 11.5.3 Rest of Latin America
11.6 Middle East and Africa
- 11.6.1 South Africa
- 11.6.2 Saudi Arabia
- 11.6.3 Rest of Middle East and Africa